National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK): all 537 studies

Page 2 of 6. Open to participants first (54), then studies with results posted, then the rest; newest registration first within each.

• Thyroid Hormones Homeostasis and Energy Metabolism Changes During Stimulation of Endogenously Secreted Bile Acids (BAs)CompletedNCT00706381Phase 3Results posted
• Myocardial Function & FFA Metabolism in HIV Metabolic SyndromeCompletedNCT00656851Not applicableResults posted
• Exercise and Pioglitazone for HIV-Metabolic SyndromesCompletedNCT00639457Not applicableResults posted
• Effects of Recombinant Human Glutamic Acid Decarboxylase on the Progression of Type 1 Diabetes in New Onset SubjectsCompletedNCT00529399Phase 2Results posted
• Tenofovir Alone Versus Tenofovir With Emtricitabine to Treat Chronic Hepatitis BTerminatedNCT00524173Phase 2Results posted
• Intravenous CTLA4-lg Treatment in Recent Onset Type 1 Diabetes MellitusCompletedNCT00505375Phase 2Results posted
• S-Adenosyl Methionine (SAMe) to Treat Patients With Chronic Hepatitis CCompletedNCT00475176Phase 2Results posted
• Botulinum Toxin Injection for the Management of BPHCompletedNCT00451191Phase 2Results posted
• Diabetes in Neuropsychiatric DisordersCompletedNCT00446992Phase 1/2Results posted
• Oral Insulin for Prevention of Diabetes in Relatives at Risk for Type 1 Diabetes MellitusCompletedNCT00419562Phase 3Results posted
• Randomized Intervention for Children With Vesicoureteral Reflux (RIVUR)CompletedNCT00405704Phase 3Results posted
• Efficacy & Safety Study of Pregabalin to Treat Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS)CompletedNCT00371033Phase 3Results posted
• Renoprotection in Early Diabetic Nephropathy in Pima IndiansCompletedNCT00340678Phase 3Results posted
• The Effects of Anti-Inflammatory Treatment on Insulin Resistance in Healthy VolunteersCompletedNCT00339833Phase 4Results posted
• Polyunsaturated Fatty Acids (PUFA) in Diabetic Fatty LiverCompletedNCT00323414Phase 2Results posted
• A Randomized, Double-Blinded, Placebo-Controlled Trial of Corticosteroid Therapy Following PortoenterostomyCompletedNCT00294684Not applicableResults posted
• Treatment of Uterine Fibroids With the Selective Progesterone Receptor Modulator CDB-2914CompletedNCT00290251Phase 2Results posted
• HALT Progression of Polycystic Kidney Disease Study ACompletedNCT00283686Phase 3Results posted
• Rituximab in New Onset Type 1 DiabetesCompletedNCT00279305Phase 2Results posted
• Effect of Lithium Carbonate on Low-Dose Radioiodine Therapy in Early Thyroid CancerCompletedNCT00251316Phase 2Results posted
• Conservative Treatment of Postprostatectomy IncontinenceCompletedNCT00212264Not applicableResults posted
• Focal Segmental Glomerulosclerosis Clinical Trial (FSGS-CT)CompletedNCT00135811Phase 3Results posted
• Pre-Transplant Treatment to Prevent Recurrence of Hepatitis C After Liver TransplantationCompletedNCT00135798Phase 2Results posted
• Efficacy of Amitriptyline for Painful Bladder Syndrome (PBS)CompletedNCT00124306Phase 3Results posted
• Thyroid and Glucose and Energy MetabolismCompletedNCT00106119Phase 2Results posted
• Trial to Compare Alfuzosin Versus Placebo in the Treatment of Chronic Prostatitis/Chronic Pelvic Pain SyndromeCompletedNCT00103402Phase 3Results posted
• PEDS-C: Pegylated Interferon +/- Ribavirin for Children With Hepatitis CCompletedNCT00100659Phase 3Results posted
• New Onset of Type 1 Diabetes Mycophenolate Mofetil-Daclizumab Clinical TrialCompletedNCT00100178Phase 2Results posted
• Podocyte RetinoidsCompletedNCT00098020Phase 2Results posted
• Effect of Metreleptin Therapy in the Treatment of Severe Insulin ResistanceActive, not recruitingNCT00085982Phase 2Results posted
• Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY)CompletedNCT00081328Phase 3Results posted
• Combination Drug Therapy Followed by Single Drug Steroid Free Therapy to Prevent Organ Rejection in Kidney TransplantationCompletedNCT00076570Phase 2Results posted
• Steroid Treatment for Kidney DiseaseCompletedNCT00065611Phase 3Results posted
• Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT)CompletedNCT00064753Phase 2/3Results posted
• Treatment of Nonalcoholic Fatty Liver Disease in Children (TONIC)CompletedNCT00063635Phase 3Results posted
• Pioglitazone vs Vitamin E vs Placebo for Treatment of Non-Diabetic Patients With Nonalcoholic Steatohepatitis (PIVENS)CompletedNCT00063622Phase 3Results posted
• Treating Nonalcoholic Steatohepatitis (NASH) With MetforminCompletedNCT00063232Phase 2Results posted
• Treating Nonalcoholic Steatohepatitis With PioglitazoneCompletedNCT00062764Phase 2Results posted
• Trial of High-dose Urso in Primary Sclerosing CholangitisTerminatedNCT00059202Phase 2/3Results posted
• Low-Dose Peginterferon and Ribavirin to Treat Chronic Hepatitis C in Patients Infected With HCV Genotype 2 or 3CompletedNCT00056862Phase 4Results posted
• Study of Thyrotropin-Releasing Hormone in Normal Volunteers and in Patients With Thyroid or Pituitary AbnormalitiesCompletedNCT00054756Phase 2Results posted
• Diabetes Prevention Program Outcomes StudyCompletedNCT00038727Phase 3Results posted
• Pegylated Interferon and Ribavirin to Treat Chronic Hepatitis C With and Without Kidney DiseaseCompletedNCT00028093Phase 4Results posted
• Leptin to Treat LipodystrophyCompletedNCT00025883Phase 2Results posted
• Pegylated Interferon to Treat Chronic Hepatitis DCompletedNCT00023322Phase 2Results posted
• Lamivudine and Adefovir to Treat Chronic Hepatitis BCompletedNCT00023309Phase 2Results posted
• Permeability Factor in Focal Segmental GlomerulosclerosisCompletedNCT00007475Phase 1/2Results posted
• Sirolimus and Thymoglobulin to Prevent Kidney Transplant RejectionCompletedNCT00006178Phase 2Results posted
• Long Term Interferon for Patients Who Did Not Clear Hepatitis C Virus With Standard TreatmentCompletedNCT00006164Phase 3Results posted
• Effectiveness of the Investigational Drug Campath-1H in Preventing Rejection of Transplanted KidneysCompletedNCT00001984Phase 2Results posted
• Pirfenidone to Treat Kidney Disease (Focal Segmental Glomerulosclerosis)CompletedNCT00001959Phase 2Results posted
• Studies of Elevated Parathyroid ActivityCompletedNCT00001277Phase 2Results posted
• Studies With 1,25-DihydroxycholecalciferolTerminatedNCT00001151Phase 2Results posted
• Pilot Study of Isocaloric Time Restricted Eating on Ketone Metabolism and ImmunoregulationCompletedNCT06169137Not applicable
• VIR-2218 and Peginterferon Alfa-2a for Chronic Hepatitis BActive, not recruitingNCT06092333Phase 2
• Peginterferon Lambda and Lonafarnib Boosted With Ritonavir 48-Week Combination Therapy for Delta HepatitisWithdrawnNCT05953545Phase 2
• Janus Kinase (JAK) Inhibitors to Preserve C-Peptide Production in New Onset Type 1 Diabetes (T1D)Active, not recruitingNCT05743244Phase 2
• Study to Determine the Response to COVID-19 Vaccination and Prevalence of COVID-19 in Subjects With Chronic Liver DiseaseCompletedNCT05669677
• Optimizing HBV Care Cascade Among Foreign-Born in the United States (FOCUS-HBV Study)CompletedNCT05621304
• The Impact of the COVID-19 Pandemic on Eating Behavior and Weight ChangeCompletedNCT04896060
• TReatment for ImmUne Mediated PathopHysiologyActive, not recruitingNCT04862221Phase 2
• Anti-TNFα to Delay or Prevent Progression to Stage 3 T1DWithdrawnNCT04729296Phase 2
• Chronic Prostatitis Collaborative Research Network Clinical Trial- Ciprofloxacin and TamsulosinCompletedNCT04552431Phase 2
• African American Study of Kidney Disease and HypertensionCompletedNCT04364139Phase 3
• The Modification of Diet in Renal Disease StudyCompletedNCT04364113Phase 3
• Rituximab-pvvr and Abatacept vs Rituximab-pvvr Alone in New Onset Type 1 DiabetesActive, not recruitingNCT03929601Phase 2
• Hepatitis B Immune Globulin (HBIg) to Restore Immune Control in People With Chronic Hepatitis BWithdrawnNCT03575208Phase 2
• People With CHC Who Achieved a Sustained Virological Response Following Therapy With Direct Acting Antiviral AgentsActive, not recruitingNCT03520660Phase 4
• Methyldopa for Reduction of DQ8 Antigen Presentation in At-Risk Subjects for Type 1 DiabetesWithdrawnNCT03396484Phase 2
• Gut Microbiome and p-Inulin in CKD - TarGut CKD StudyStatus unknownNCT03348592Not applicable
• Clopidogrel Prevention of Early Arteriovenous (AV) Fistula ThrombosisCompletedNCT03289520Phase 3
• Hepatitis B Reactivation During Treatment With Direct-Acting Antiviral Agents for Chronic Hepatitis C InfectionCompletedNCT03248622
• Effect of Isocaloric Ultra Processed Versus Unprocessed Diets on Insulin SensitivityCompletedNCT03189121
• Empaglifozin in Early Diabetic Kidney DiseaseWithdrawnNCT03173963Phase 3
• The Physiological Responses and Adaptation of Brown Adipose Tissue to Chronic Treatment With Beta3-Adrenergic Receptor AgonistsCompletedNCT03049462Phase 1
• Longitudinal Assessment of Transient Elastography in Cystic FibrosisCompletedNCT03001388
• MRI to Characterize and Predict CF Liver Disease in PUSH CohortCompletedNCT02979340
• Measuring and Improving Medication Adherence in Kidney Transplant PatientsCompletedNCT02639949Not applicable
• A Phase 1 Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ManNAc in Subjects With Primary Podocyte DiseasesCompletedNCT02639260Phase 1
• Quantifying the Persistence of Metabolic Adaptation and Weight Regain Following Extreme Weight LossCompletedNCT02544009
• Dynamic Post-Prandial Metabolism in Patients With Non-Alcoholic Fatty Liver DiseaseCompletedNCT02520609
• Acute Effects of Canagliflozin, a Sodium Glucose Co-Transporter 2 (SGLT2) Inhibitor on Bone Metabolism in Healthy VolunteersCompletedNCT02404870Phase 1
• Deciphering the Mechanisms Involved in Microbial Translocation Across the Spectrum of HCV Associated Liver FibrosisCompletedNCT02400216
• Palmitate Breath Test to Assess Fatty Acid Oxidation in Non Alcoholic Fatty Liver Disease (NAFLD)CompletedNCT02363309
• Cross Calibration of Two Dual Energy Densitometers and Comparison of Regional Adipose Tissue Measurements by iDXA and MRICompletedNCT02346474
• Comparing Pain in Patients Undergoing Percutaneous Versus Transjugular Techniques of Liver BiopsyCompletedNCT02311348
• TODAY2 Phase 2 Follow-upCompletedNCT02310724
• Compassionate Use of Metreleptin in Previously Treated People With Generalized LipodystrophyActive, not recruitingNCT02262832Phase 3
• Compassionate Use of Metreleptin in Previously Treated People With Partial LipodystrophyActive, not recruitingNCT02262806Phase 2
• Metabolic and Neural Adaptations to Weight Loss, Plateau, and RegainWithdrawnNCT02199483
• Seroprevalence of Hepatitis E in People With an Organ TransplantCompletedNCT02190253
• Study of the Effect of a Very-Low-Carbohydrate Diet on Energy ExpenditureTerminatedNCT01967563
• Evaluation of Sickle Cell Liver DiseaseCompletedNCT01950429
• Mechanisms of Diabetic Kidney Disease in American IndiansCompletedNCT01878045
• The Physiology of Fatigue in Patients With Chronic Liver DiseaseCompletedNCT01867385
• Lifestyle Interventions for Expectant Mothers (LIFE-Moms Phoenix) - PhoenixCompletedNCT01812694Phase 3
• Identifying Risk for Diabetes and Heart Disease in WomenCompletedNCT01809288
• Effects of Thyroid Hormone Enzyme Blocking on HypothyroidismWithdrawnNCT01801033
• Chronic Cold Exposure and Energy Metabolism in HumansCompletedNCT01730105
• Evaluation of People With Gastrointestinal DiseaseCompletedNCT01639924

← National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) overview and focus areas